pizotifen 1.5mg tablets
medihealth (northern) ltd - pizotifen hydrogen malate - oral tablet - 1.5mg
pizofen 0.5mg tablet 0.5 mg
الشركة الأردنية لإنتاج الأدوية - jordan pharmaceutical manufacturer (jpm) - pizotifen 0.5 mg - 0.5 mg
pizofen 0.5mg tablet 0.5 mg
الشركة الأردنية لإنتاج الأدوية - jordan pharmaceutical manufacturer (jpm) - pizotifen 0.5 mg - 0.5 mg
pizofen 1mg tablet 1 mg
الشركة الأردنية لإنتاج الأدوية - jordan pharmaceutical manufacturer (jpm) - pizotifen 1 mg - 1 mg
pizofen syrup 0.25 mg/5ml
الشركة الأردنية لإنتاج الأدوية - jordan pharmaceutical manufacturer (jpm) - pizotifen 0.25 mg/5ml - 0.25 mg/5ml
mosegor 0.5mg sugar coated tablets
ethyx pharmaceuticals, france - pizotifen - coated tablet - 0.5 mg
mosegor syrup
novartis pharma ag, switzerland - pizotifen - syrup - 50 µ/ml
sanomigran 500 microgram tablets
phoenix labs - pizotifen - coated tablet - 500 microgram(s) - other antimigraine preparations; pizotifen - antimigraine drug - prophylactic treatment of recurrent vascular headaches, including classical migraine, common migraine and cluster headache (periodic migrainous neuralgia). the international classification of headache disorders 2nd edition (ichd-ii) are standard classifications of headache used by healthcare professionals and describe the above-mentioned disorders as follows: prophylactic treatment of recurrent migraine headache with or without aura and of cluster headache. sanomigran is not effective in relieving migraine attacks once in progress.
sanomigran 1.5mg tablets
phoenix labs - pizotifen - coated tablet - 1.5 milligram(s) - other antimigraine preparations; pizotifen - antimigraine drug - prophylactic treatment of recurrent vascular headaches, including classical migraine, common migraine and cluster headache (periodic migrainous neuralgia). sanomigran is not effective in relieving migraine attacks once in progress. the international classification of headache disorders 2nd edition (ichd-ii) are standard classifications of headache used by healthcare professionals and describe the above-mentioned disorders as follows: prophylactic treatment of recurrent migraine headache with or without aura and of cluster headache.